-
ISSCR Statement of Delivery of Unproven Autologous Cell-based Interventions to Patients
The International Society for Stem Cell Research (ISSCR) urges medical licensing bodies, legal authorities, patient advocacy organizations, physicians, and others to exercise their influence to discourage commercial provision of unproven autologous cell-based interventions outside of clinical trials.Full story -
ISSCR Celebrates Inaugural Issue of its Open Access Journal, Stem Cell Reports
The International Society for Stem Cell Research (ISSCR) is excited to announce the inaugural issue of Stem Cell Reports, the society’s new open-access journal, published today. Stem Cell Reports, published for the ISSCR by Cell Press, presents high-quality, peer-reviewed research presenting conceptual or practical advances across the breadth of stem cell research and its applications to medicine, with a focus on shorter, single-point articles.Full story -
ISSCR Emphasizes Importance of Regulatory Oversight for Stem Cell Products for Clinical Use
The ISSCR urges Italian lawmakers to heed concerns of scientists around the world about the premature practice of unproven stem cell treatments and to recognize the importance of regulatory oversight and patient protection when developing new stem cell medicines.Full story -
ISSCR Voices Concern as Italian Government Authorizes Unproven Stem Cell Therapy
The International Society for Stem Cell Research (ISSCR) voices concern as the Italian government authorizes an unproven stem cell therapy for use in patients.Full story -
ISSCR President, Board Member, and 11th Annual Meeting Keynote Speaker Among Winners of Breakthrough Prize
ISSCR President, Shinya Yamanaka, Board of Directors member Hans Clevers and the ISSCR 2013 Annual Meeting Keynote Speaker Eric Lander, were three of 11 distinguished recipients of the inaugural Breakthrough Prize in Life Sciences, announced todayFull story
Media Contact
